RE:Best adviceSame boat. I sold Organigram(entry $1.65), Canopy (entry was $3.65, Radient Technologies (entry .17) and MYM far too early. New investor as of summer 16’ so I’ve learned a lot in the year plus. As work got busier I stopped looking at my account and was happy to hold the mmj from my .06 entry and came to look at it a week ago to find it almost a 3 bagger. I don’t think you can go wrong with this investment if your willing to wait it out a bit. It very well may drift lower while awaiting milestones but I think long term this will be $1.50-$2 before acquisition talks kick in to try and centralize this majority fragmented sector. Point is that the license and facilities is all they need to get there as money can’t make the process go faster and that makes the shares worth more IMO than the balance sheet says.